Status:
COMPLETED
A Study Of Diflucan In Children With Ringworm Of The Scalp
Lead Sponsor:
Pfizer
Conditions:
Tinea Capitis
Eligibility:
All Genders
3-12 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate the safety and efficacy of fluconazole for the treatment of tinea capitis in pediatric patients aged 3 to 12 years.
Eligibility Criteria
Inclusion
- Pediatric patients (aged 3-12 years)
- Clinical diagnosis of tinea capitis
- Direct microscopy (KOH) positive for fungal elements within or outside hair shaft
Exclusion
- Negative baseline KOH
- Liver disease
Key Trial Info
Start Date :
November 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2003
Estimated Enrollment :
185 Patients enrolled
Trial Details
Trial ID
NCT00645242
Start Date
November 1 2002
End Date
March 1 2003
Last Update
July 16 2021
Active Locations (31)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Montgomery, Alabama, United States, 36116
2
Pfizer Investigational Site
Little Rock, Arkansas, United States, 72205
3
Pfizer Investigational Site
San Diego, California, United States, 92123
4
Pfizer Investigational Site
Miami, Florida, United States, 33156-7712